These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1732537)

  • 1. Stereoselective LSD-like activity in d-lysergic acid amides of (R)- and (S)-2-aminobutane.
    Oberlender R; Pfaff RC; Johnson MP; Huang XM; Nichols DE
    J Med Chem; 1992 Jan; 35(2):203-11. PubMed ID: 1732537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives.
    Huang X; Marona-Lewicka D; Pfaff RC; Nichols DE
    Pharmacol Biochem Behav; 1994 Mar; 47(3):667-73. PubMed ID: 8208787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective LSD-like activity in a series of d-lysergic acid amides of (R)- and (S)-2-aminoalkanes.
    Monte AP; Marona-Lewicka D; Kanthasamy A; Sanders-Bush E; Nichols DE
    J Med Chem; 1995 Mar; 38(6):958-66. PubMed ID: 7699712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups.
    Monte AP; Marona-Lewicka D; Parker MA; Wainscott DB; Nelson DL; Nichols DE
    J Med Chem; 1996 Jul; 39(15):2953-61. PubMed ID: 8709129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).
    Nichols DE; Frescas S; Marona-Lewicka D; Kurrasch-Orbaugh DM
    J Med Chem; 2002 Sep; 45(19):4344-9. PubMed ID: 12213075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2,3-Dihydrobenzofuran analogues of hallucinogenic phenethylamines.
    Nichols DE; Snyder SE; Oberlender R; Johnson MP; Huang XM
    J Med Chem; 1991 Jan; 34(1):276-81. PubMed ID: 1992127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a chiral 4-alkyl substituent in hallucinogenic amphetamines.
    Oberlender R; Ramachandran PV; Johnson MP; Huang X; Nichols DE
    J Med Chem; 1995 Sep; 38(18):3593-601. PubMed ID: 7658446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
    Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
    J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
    Titeler M; Lyon RA; Glennon RA
    Psychopharmacology (Berl); 1988; 94(2):213-6. PubMed ID: 3127847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis.
    Sadzot B; Baraban JM; Glennon RA; Lyon RA; Leonhardt S; Jan CR; Titeler M
    Psychopharmacology (Berl); 1989; 98(4):495-9. PubMed ID: 2505289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain.
    Gerasimov M; Marona-Lewicka D; Kurrasch-Orbaugh DM; Qandil AM; Nichols DE
    J Med Chem; 1999 Oct; 42(20):4257-63. PubMed ID: 10514296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists.
    McLean TH; Parrish JC; Braden MR; Marona-Lewicka D; Gallardo-Godoy A; Nichols DE
    J Med Chem; 2006 Sep; 49(19):5794-803. PubMed ID: 16970404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).
    Halberstadt AL; Klein LM; Chatha M; Valenzuela LB; Stratford A; Wallach J; Nichols DE; Brandt SD
    Psychopharmacology (Berl); 2019 Feb; 236(2):799-808. PubMed ID: 30298278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzofuran bioisosteres of hallucinogenic tryptamines.
    Tomaszewski Z; Johnson MP; Huang X; Nichols DE
    J Med Chem; 1992 May; 35(11):2061-4. PubMed ID: 1534585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.
    Blair JB; Marona-Lewicka D; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
    J Med Chem; 1999 Mar; 42(6):1106-11. PubMed ID: 10090793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
    Glennon RA; Titeler M; McKenney JD
    Life Sci; 1984 Dec; 35(25):2505-11. PubMed ID: 6513725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.